Bullish case
$44 to $55
More likely if Avient shows sustained revenue growth from packaging and healthcare end markets, operating margins expand past 15%, and the stock recovers toward the 52-week high of $44.85 and above with volume confirmation.
Avient Corporation research snapshot
AVNT AI Stock Analysis
AVNT AI stock analysis currently reads Avient Corporation as a specialty polymer materials company whose share price has recovered 31% from the 52-week low of $27.48 but still sits 20% below the 52-week high of $44.85. At the July 12, 2026 data cutoff, AVNT traded at $36.03 with a verified market capitalization near $3.30 billion and a P/E of roughly 21x. The company generates about $3.3 billion in annual revenue with EBITDA margins near 14%, but carries meaningful debt from its compounding and M&A history. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$36.03
Market cap
$3.30 billion
AI score
52 / 100
Rating
Cyclical value at mid-cycle multiple, debt overhang
Trend status
Recovering from 52-week low, below 52-week high
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- B-level information richness. Avient has over two decades of public filings and full analyst coverage from 6+ sell-side firms including Baird, Morgan Stanley, Wells Fargo, KeyBanc, Oppenheimer, and Seaport Global. Some segment-level detail requires inference from annual reports.
- bias Check
- The main AI bias risk is anchoring on the recent earnings beat (Q1 2026 EPS of $0.83 vs $0.81 estimate) as an inflection signal, when the underlying end-market demand in packaging, building & construction, and healthcare remains mixed. The reverse check asks whether the current 21x P/E properly reflects the cyclicality and debt load of the business.
- ai Confidence
- High for verified market cap, share count, P/E, revenue, and point-in-time quote calculations. Medium for forward estimates and scenario ranges because specialty chemical earnings depend on raw material costs, end-market demand shifts, and debt service costs.
- investment Certainty
- Medium-low. Avient has an understandable business model and a track record in polymer formulation, but the stock at 21x earnings with $2.3B+ in net debt and a net income to EBITDA conversion ratio below 20% implies limited margin of safety. Investment certainty is lower than data confidence because the balance sheet leverage reduces the margin for error.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Avient formulates specialty polymer colorants, additives, and engineered materials sold to packaging, building & construction, healthcare, and consumer goods end markets globally. | Medium |
| Moat | Moat comes from customer formulation lock-in, technical service relationships, regulatory certifications, and a global manufacturing footprint. Switching costs are moderate but not impenetrable. | Medium |
| Management | CEO Ashish Khandpur (since 2024) took over after a transition from former long-time CEO Robert Patterson. Capital allocation discipline, debt reduction, and margin execution are the key metrics to watch. | Medium |
| Financial trend | Revenue and market cap verified mechanically. TTM revenue approximately $3.26B with net income near $158M. EBITDA margin near 14% with meaningful debt service costs compressing net income conversion. | Source gap noted |
| Valuation | At 20.95x TTM earnings and an estimated EV/EBITDA near 9-10x, the stock trades within a reasonable range for specialty chemicals but with limited upside to the $43-52 analyst target range without earnings acceleration. | Medium-low |
| Technical trend | Recovering trend from the $27.48 low. Support near $32-34, resistance near $40-45. The stock has rallied year-to-date but volume has not confirmed a strong breakout pattern yet. | Medium |
| Risk level | The thesis can fail if raw material cost inflation returns, end-market demand softens further, debt service costs rise with higher interest rates, or margins compress from competitive pricing pressure. | Medium-high |
| AI confidence | High data confidence for point-in-time metrics and quote verification. Lower confidence for forward returns given specialty chemical cyclicality and balance sheet leverage. | High data confidence |
| Investment certainty | Medium-low certainty because this page provides a research framework, not a personalized buy or sell decision. | Medium-low |
AVNT AI stock forecast
AVNT AI Stock Forecast Scenarios
The AVNT AI stock forecast uses scenario ranges around the $36.03 quote rather than a point target. The bullish case requires sustained demand recovery and margin expansion; the base case assumes mid-cycle conditions for specialty chemicals; the bearish case assumes end-market weakness and debt pressure.
Base case
$32 to $43
More likely if end-market demand conditions remain mixed but the stock trades within the analyst target range of $43-52 at the upper end, with continued debt reduction supporting earnings quality.
Bearish case
$24 to $31
More likely if raw material cost inflation returns, end-market demand softens in packaging and building & construction, or debt service costs pressure free cash flow and the P/E multiple contracts below 15x.
AVNT AI technical analysis
AVNT AI Technical Analysis
AVNT AI technical analysis starts from the $36.03 quote after a year-to-date recovery from the 52-week low of $27.48. Because this static page does not fetch request-time chart data, moving averages and live momentum should be confirmed in a charting tool before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $36.03 | Current quote as of the July 12, 2026 data cutoff. |
| Near support | $32 to $34 | Estimated from the recent price action lows. Treat as a planning zone, not a guaranteed floor. |
| Near resistance | $40 to $45 | The 52-week high at $44.85 is a key resistance level. A close above $40 with volume could confirm a trend reversal. |
| 50-day moving average | Requires live chart confirmation | Use current chart data before acting. The page does not fetch request-time market data. |
| 200-day moving average | Requires live chart confirmation | Long-term trend confirmation should be checked against a live chart or broker data. |
| Momentum | Recovering momentum from 52-week low, overbought risk moderate | The stock has recovered approximately 31% from the 52-week low of $27.48. Momentum is positive but volume remains below average. |
| Volume | Below average snapshot | Recent volume near 849K is below the 985K average, which can reduce reliability of breakout signals. |
| Volatility | Moderate monitoring priority | Beta estimates range from 0.82 to 1.27 depending on source, suggesting moderate correlation with broad market moves. |
| Invalidation | Close below $32 | A decisive close below the $32 support zone would break the recovery structure and could lead to a re-test of the 52-week low. |
AVNT AI trading strategy
AVNT AI Trading Strategy Framework
The AVNT AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, and checks of fresh filings and specialty chemicals cycle indicators.
Trend-following setup
Wait for AVNT to hold above $34 support and confirm a push through $40 with above-average volume before initiating a long position.
A close below $32 or failure to break resistance with volume should invalidate the setup.
Mean-reversion setup
If AVNT pulls back toward the $32-34 zone without a fundamental thesis break, compare price action with the next earnings report and specialty chemicals demand indicators.
Do not average down without a predefined maximum loss and a fresh review of end-market demand, raw material costs, and debt reduction progress.
Fundamental monitor
Track the evidence that matters most for specialty chemicals: revenue growth by end-market (packaging, healthcare, building & construction), EBITDA margin trajectory, debt-to-EBITDA reduction, free cash flow conversion, and management execution.
Reduce confidence when price moves are driven by raw material speculation without matching end-market demand or margin improvement.
Investment research summary
Four-master Research Compression
Business essence
Avient formulates and sells specialty polymer colorants, additives, and engineered materials to manufacturers in packaging, healthcare, building & construction, and consumer goods globally.
Moat
Avient moat comes from customer formulation lock-in, long-standing supplier relationships, regulatory certifications for healthcare and food-contact applications, and a global manufacturing network that creates moderate switching costs.
Munger risk inversion
The thesis can fail if raw material cost inflation compresses margins, end-market demand weakens across packaging and construction, debt service costs rise, or competitive pressure from lower-cost regional producers intensifies.
Management
CEO Ashish Khandpur took the helm in 2024 after a long-tenured predecessor. Capital allocation strategy around debt reduction, organic investment versus M&A, and margin execution are the key metrics to track for new leadership.
Industry trend
Specialty chemicals is a cyclical but stable industry benefiting from long-term plastics substitution trends and regulatory-driven demand for specialty formulations. Near-term headwinds from mixed end-market demand and raw material volatility remain.
Valuation and margin of safety
At 20.95x TTM earnings and an estimated EV/EBITDA of 9-10x, AVNT trades at a mid-cycle specialty chemicals valuation. The analyst target range of $43-52 suggests potential upside if earnings expand, but the balance sheet leverage provides limited margin of safety.
Source-backed data
AVNT Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| AVNT price | $36.03 | Google Finance close price cross-checked with TradingView | July 12, 2026 |
| Market capitalization | $3.30 billion or $36.03 x 91.71M implied shares | financial_rigor.py market cap verification passed with 0.13% deviation | July 12, 2026 |
| Exchange | NYSE | TradingView and Google Finance | July 12, 2026 |
| TTM revenue | $3.26B (trailing 4 quarters: $866.5M + $806.5M + $760.6M + $847.4M) | Google Finance quarterly revenue data | July 12, 2026 |
| TTM net income | $157.8M (trailing 4 quarters: $52.6M + $32.6M + $16.9M + $55.7M) | Google Finance quarterly income data | July 12, 2026 |
| P/E ratio (TTM) | 20.95x | financial_rigor.py valuation verification | July 12, 2026 |
| EPS (TTM) | $1.72 | Google Finance and TradingView key stats | July 12, 2026 |
| EBITDA (TTM) | $535.3M | TradingView key statistics | July 12, 2026 |
| Dividend yield | 3.11% ($1.12 annual, $0.28 quarterly) | Google Finance dividend data cross-checked with TradingView | July 12, 2026 |
| Enterprise value | Requires debt and cash data from latest 10-Q to calculate precisely | Data gap: debt and cash figures not available from free sources at data cutoff | July 12, 2026 |
Frequently Asked Questions
Use Pineify AI Stock PickerBuild an AI trading strategyRun an AI stock screenerRead the EMN AI stock analysisView the ALB AI stock analysis
This AVNT AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 12, 2026, may be incomplete, and can be wrong if new filings, market prices, company events, or macro conditions change.
Related Tools
Trading Strategy Builder
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Try it
Stock Screener
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Try it
AI Stock Picker & Screener
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
Try it